A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation, In-Patient Phase I/II Study to Determine the Safety and Immunogenicity of Ty800 in Healthy Adult Subjects.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Typhoid vaccine Ty800 (Primary)
- Indications Typhoid
- Focus Adverse reactions; Pharmacodynamics
- 21 May 2007 Status changed from in progress to completed
- 22 Aug 2006 Status change
- 22 Feb 2006 New trial record.